UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
_________________
FORM 8-K
_________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of Earliest Event Reported):
February 16, 2021
USANA HEALTH SCIENCES, INC.
(Exact name of registrant as specified in its charter)
Utah
(State or other jurisdiction of incorporation)
|
001-35024
|
|
87-0500306
|
|
(Commission File No.)
|
|
(IRS Employer
Identification No.)
|
3838 West Parkway Boulevard
Salt Lake City,
Utah 84120
(Address of principal executive offices, Zip Code)
Registrant's telephone number, including area code: (801) 954-7100
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐ Written communications pursuant to Rule 425
under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12
under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to
Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to
Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
|
Title of each class
|
|
Trading Symbol(s)
|
|
Name of each exchange on which registered
|
|
Common Stock, $0.001 per value per share
|
|
USNA
|
|
New York Stock Exchange
|
Indicate by check mark whether the registrant is an emerging growth company as defined
in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any
new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 7.01 Regulation
FD Disclosure.
The information disclosed below under Item 8.01is incorporated herein by reference.
Item 8.01 Other
Events.
On February 16, 2021, the Company issued a press release announcing that its Board of Directors has formed a Sustainability Committee to oversee and advise on
all matters related to corporate sustainability, including environmental, social and governance and corporate social responsibility matters.
Item 9.01 Financial
Statements and Exhibits.
(d) Exhibits
|
|
Exhibit No. |
|
Description |
|
|
99.1
|
|
Press release issued by USANA Health Sciences, Inc. dated February 16, 2021 (furnished herewith). |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
|
USANA HEALTH SCIENCES, INC. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
By:
|
G. Douglas Hekking |
|
|
G. Douglas Hekking, Chief Financial Officer |
Date: February 16, 2021
Exhibit Index